DK1002084T3 - Mammalt cytokin: interleukin-B30 og beslægtede reagenser - Google Patents

Mammalt cytokin: interleukin-B30 og beslægtede reagenser

Info

Publication number
DK1002084T3
DK1002084T3 DK98937105T DK98937105T DK1002084T3 DK 1002084 T3 DK1002084 T3 DK 1002084T3 DK 98937105 T DK98937105 T DK 98937105T DK 98937105 T DK98937105 T DK 98937105T DK 1002084 T3 DK1002084 T3 DK 1002084T3
Authority
DK
Denmark
Prior art keywords
interleukin
related reagents
mammalian cytokine
cytokine
mammalian
Prior art date
Application number
DK98937105T
Other languages
English (en)
Inventor
J Fernando Bazan
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25413278&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1002084(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK1002084T3 publication Critical patent/DK1002084T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK98937105T 1997-07-25 1998-07-24 Mammalt cytokin: interleukin-B30 og beslægtede reagenser DK1002084T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90090597A 1997-07-25 1997-07-25
PCT/US1998/015423 WO1999005280A1 (en) 1997-07-25 1998-07-24 Mammalian cytokine: interleukin-b30 and related reagents

Publications (1)

Publication Number Publication Date
DK1002084T3 true DK1002084T3 (da) 2010-01-04

Family

ID=25413278

Family Applications (2)

Application Number Title Priority Date Filing Date
DK09156327.0T DK2100959T3 (da) 1997-07-25 1998-07-24 Pattedyrscytokin: Interleukin-B30 og tilhørende reagenser
DK98937105T DK1002084T3 (da) 1997-07-25 1998-07-24 Mammalt cytokin: interleukin-B30 og beslægtede reagenser

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK09156327.0T DK2100959T3 (da) 1997-07-25 1998-07-24 Pattedyrscytokin: Interleukin-B30 og tilhørende reagenser

Country Status (28)

Country Link
EP (3) EP2100959B1 (da)
JP (5) JP4316133B2 (da)
KR (1) KR100666835B1 (da)
CN (2) CN101851286A (da)
AR (2) AR017510A1 (da)
AT (1) ATE443142T1 (da)
AU (1) AU741046B2 (da)
BR (1) BR9811039A (da)
CA (1) CA2296272C (da)
CO (1) CO4810232A1 (da)
CZ (1) CZ300958B6 (da)
DE (1) DE69841161D1 (da)
DK (2) DK2100959T3 (da)
ES (2) ES2331762T3 (da)
HU (1) HU230629B1 (da)
ID (1) ID28114A (da)
IL (3) IL134068A0 (da)
LT (1) LT2100959T (da)
MY (1) MY157028A (da)
NO (1) NO329329B1 (da)
NZ (1) NZ502391A (da)
PE (1) PE20000183A1 (da)
PL (1) PL197150B1 (da)
PT (2) PT2100959T (da)
SK (1) SK287198B6 (da)
TW (1) TWI237057B (da)
WO (1) WO1999005280A1 (da)
ZA (1) ZA986596B (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060284A (en) 1997-07-25 2000-05-09 Schering Corporation DNA encoding interleukin-B30
ATE329928T1 (de) * 1997-10-23 2006-07-15 Nippon Inst For Biolog Science Granulozyten-kolonie-stimulierender faktor aus der katze
AU2661199A (en) * 1998-02-06 1999-08-23 Schering Corporation Mammalian receptor proteins; related reagents and methods
ATE474849T1 (de) * 1998-04-14 2010-08-15 Chugai Pharmaceutical Co Ltd Neues cytokinartiges protein
EP1905832A3 (en) 1999-09-09 2009-09-09 Schering Corporation Mammalian interleukin-12 P40 and interleukin B30, combinations thereof, antibodies, uses in pharmaceutical compositions
US7090847B1 (en) 1999-09-09 2006-08-15 Schering Corporation Mammalian cytokines; related reagents and methods
AU2005202420B2 (en) * 1999-09-09 2008-08-07 Merck Sharp & Dohme Corp. Mammalian cytokines; related reagents and methods
DE60038304T3 (de) * 1999-09-09 2017-04-06 Merck Sharp & Dohme Corp. Interleukin-12 p40 und interleukin-b30. kombinationen davon. antikörper. verwendungen in pharmazeutische zusammensetzungen
NZ539271A (en) 2002-10-30 2008-12-24 Genentech Inc Inhibition of the production of proinflammatory cytokine interleukin-17 (IL-17) by T cells, using an antagonist of interleukin-23 (IL-23)
EP1623011B1 (en) 2003-05-09 2013-01-02 Janssen Biotech, Inc. Il-23p40 specific immunoglobulin derived proteins, compositions, methods and uses
WO2005108425A1 (en) * 2004-05-10 2005-11-17 Cytos Biotechnology Ag Il-23 p19 antigen array and uses thereof
AR051444A1 (es) 2004-09-24 2007-01-17 Centocor Inc Proteinas derivadas de inmunoglobulina especifica de il-23p40, composiciones, epitopos, metodos y usos
CA2613818C (en) 2005-06-30 2013-08-27 Centocor, Inc. Anti-il-23 antibodies, compositions, methods and uses
SI3219328T1 (sl) 2005-12-29 2020-10-30 Janssen Biotech, Inc. Človeška protitelesa proti-IL-23, sestavki, postopki in uporabe
US7910703B2 (en) 2006-03-10 2011-03-22 Zymogenetics, Inc. Antagonists to IL-17A, IL-17F, and IL-23P19 and methods of use
JP2009540018A (ja) 2006-06-13 2009-11-19 ザイモジェネティクス， インコーポレイテッド Ｉｌ−１７およびｉｌ−２３アンタゴニストならびにその使用方法
TWI426918B (zh) 2007-02-12 2014-02-21 Merck Sharp & Dohme Ｉｌ-２３拮抗劑於治療感染之用途
CA2706425A1 (en) 2007-11-27 2009-06-04 Ablynx N.V. Method for obtaining polypeptide constructs comprising two or more single domain antibodies
BRPI0908312A2 (pt) 2008-05-05 2015-08-18 Novimmune Sa '' anticorpo monoclonal totalmente humano isolado, composição farmacêutica, método de alívio de um sintoma de uma indicação clínica e método de alívio de um sintoma de uma doença autoimune, distúrbio inflamatório ou distúrbio da proliferação celular''
EP2427203B1 (en) 2009-05-05 2018-10-17 Novimmune S.A. Anti-il-17f antibodies and use thereof
JO3244B1 (ar) 2009-10-26 2018-03-08 Amgen Inc بروتينات ربط مستضادات il – 23 البشرية
KR102049223B1 (ko) 2010-11-04 2019-11-28 베링거 인겔하임 인터내셔날 게엠베하 항－ｉｌ－２３ 항체
CN109206516A (zh) 2012-05-03 2019-01-15 勃林格殷格翰国际有限公司 抗IL-23p19抗体
EP3689369A1 (en) 2013-03-15 2020-08-05 Amgen, Inc Methods for treating psoriasis using an anti-il-23 antibody
US20160031983A1 (en) 2013-03-15 2016-02-04 Amgen Inc. Methods for treating crohn's disease using an anti-il23 antibody
EP3172339A1 (en) 2014-07-24 2017-05-31 Boehringer Ingelheim International GmbH Biomarkers useful in the treatment of il-23a related diseases
CA2959629C (en) 2014-09-03 2023-10-31 Boehringer Ingelheim International Gmbh Compound targeting il-23a and tnf-alpha and uses thereof
KR20170120616A (ko) 2015-02-04 2017-10-31 베링거 인겔하임 인터내셔날 게엠베하 염증성 질환의 치료 방법
MX2018003376A (es) 2015-09-17 2018-08-15 Amgen Inc Prediccion de la respuesta clinica a antagonistas de il23 mediante el uso de biomarcadores de la via de il23.
WO2017112536A1 (en) 2015-12-22 2017-06-29 Amgen Inc. Ccl20 as a predictor of clinical response to il23-antagonists
JP2021532176A (ja) 2018-07-13 2021-11-25 アストラゼネカ・コラボレイション・ベンチャーズ・リミテッド・ライアビリティ・カンパニーAstrazeneca Collaboration Ventures, Llc ブラジクマブによる潰瘍性大腸炎の処置
MA55149A (fr) 2018-11-20 2021-09-29 Janssen Biotech Inc Procédé sûr et efficace de traitement du psoriasis avec un anticorps spécifique anti-il-23
EP3972690A4 (en) 2019-05-23 2023-07-05 Janssen Biotech, Inc. METHOD OF TREATMENT OF INFLAMMATORY BOWEL DISEASE USING COMBINATION THERAPY OF ANTIBODIES TO IL-23 AND TNF-ALPHA
TW202535466A (zh) 2019-09-09 2025-09-16 德商百靈佳殷格翰國際股份有限公司 抗-il-23p19抗體調配物
CA3164996A1 (en) 2019-12-20 2021-06-14 Novarock Biotherapeutics, Ltd. Anti-interleukin-23 p19 antibodies and methods of use thereof
CA3183927A1 (en) 2020-05-21 2021-11-25 Janssen Biotech, Inc. Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2031216A1 (de) 1969-06-19 1971-01-14 Citizen Watch Co Ltd , Tokio Tag und Datum Stellvorrichtung fur Uhren mit Kalender
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
EP0088994B1 (en) 1982-03-15 1991-06-19 Schering Corporation Hybrid dna, binding composition prepared thereby and processes therefor
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5891680A (en) * 1995-02-08 1999-04-06 Whitehead Institute For Biomedical Research Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12
ATE474849T1 (de) * 1998-04-14 2010-08-15 Chugai Pharmaceutical Co Ltd Neues cytokinartiges protein

Also Published As

Publication number Publication date
NO20000343L (no) 2000-03-24
SK287198B6 (sk) 2010-03-08
IL134068A (en) 2010-11-30
JP2005323610A (ja) 2005-11-24
AU741046B2 (en) 2001-11-22
KR20010022214A (ko) 2001-03-15
NO20000343D0 (no) 2000-01-24
WO1999005280A1 (en) 1999-02-04
BR9811039A (pt) 2000-08-08
IL205765A0 (en) 2011-07-31
EP2100959B1 (en) 2016-12-07
NZ502391A (en) 2002-12-20
CO4810232A1 (es) 1999-06-30
KR100666835B1 (ko) 2007-01-11
JP2015037405A (ja) 2015-02-26
DE69841161D1 (de) 2009-10-29
ES2610483T3 (es) 2017-04-27
AR017510A1 (es) 2001-09-12
JP2001511347A (ja) 2001-08-14
ES2331762T3 (es) 2010-01-14
LT2100959T (lt) 2017-01-10
NO329329B1 (no) 2010-09-27
AU8589498A (en) 1999-02-16
JP2010011863A (ja) 2010-01-21
HU230629B1 (hu) 2017-04-28
HK1024932A1 (en) 2000-10-27
HUP0004019A2 (en) 2001-03-28
PL338262A1 (en) 2000-10-09
ZA986596B (en) 1999-02-08
EP2100959A3 (en) 2009-10-14
CZ2000263A3 (cs) 2000-06-14
EP1002084A1 (en) 2000-05-24
CN101851286A (zh) 2010-10-06
IL134068A0 (en) 2001-04-30
AR086483A2 (es) 2013-12-18
TWI237057B (en) 2005-08-01
HUP0004019A3 (en) 2003-08-28
JP2013034480A (ja) 2013-02-21
ID28114A (id) 2001-05-03
SK912000A3 (en) 2000-09-12
PL197150B1 (pl) 2008-03-31
DK2100959T3 (da) 2017-01-30
CN1271387A (zh) 2000-10-25
EP1002084B1 (en) 2009-09-16
EP2233574A1 (en) 2010-09-29
IL205765A (en) 2015-07-30
MY157028A (en) 2016-04-15
CA2296272A1 (en) 1999-02-04
PE20000183A1 (es) 2000-03-11
JP4316133B2 (ja) 2009-08-19
CZ300958B6 (cs) 2009-09-23
PT1002084E (pt) 2009-12-16
EP2100959A2 (en) 2009-09-16
CA2296272C (en) 2012-03-13
PT2100959T (pt) 2017-01-09
ATE443142T1 (de) 2009-10-15

Similar Documents

Publication Publication Date Title
NO20000343D0 (no) Pattedyr-cytokin:interleukin-B30 og beslektede reagenser
IL148300A0 (en) Mammalian cytokines; related reagents and methods
NO985339D0 (no) Humane B-celleantigener og beslektede reagenser
DK0915880T3 (da) Azolotriaziner og pyrimidiner
NO964583D0 (no) Lettvekts brönnsementsammensetninger og fremgangsmåter
NO20000700D0 (no) Interleukin-18-proteiner samt fremstilling og anvendelse derav
AU7103198A (en) Mammalian cytokines; related reagents and methods
NO994009D0 (no) Gensekvensator og metoder
DE69816431D1 (de) Taupunkt- und blasenpunktmessung
IS5525A (is) Innúðabúnaður og aðferð
DE69822917D1 (de) Abtast- und Halteschaltung
NO972236D0 (no) Dihydropyrimidiner og anvendelse derav
NO980255L (no) Antiparasittiske marcfortiner og paraherkvamider
NO981282D0 (no) Calcitriolderivater og deres anvendelser
NO985806D0 (no) Kitinasematerialer og fremgangsmÕter
NO983238D0 (no) Exodus kjemokin materialer og fremgangsmater
NO971505D0 (no) Trofinin og trofininhjelperproteiner
NO995308D0 (no) Sammensetning og fremgangsmÕter som anvender en eutomer
CY2005003I1 (el) Μεθοδοι και ενδιαμεσα χρησιμα για κατασκευη αντιφολικων
NO951499D0 (no) Signal-generator og trådlöst mobilsystem
DE69515383D1 (de) Abtast- und Halteschaltung
NO993805D0 (no) Fremgangsmåte for mottaking og mottaker
NO984233D0 (no) Cytokin kalt lerk-8
EP1016482A4 (en) DEVICE AND METHOD FOR FLYING CUTTING
KR970006959U (ko) 휴대용 깃대